Major goals of the COBRE III Center are to increase the scope of research conducted in Montana related to zoonotic and emerging infectious diseases and to continue increasing the competitiveness of Montana investigators for extramural funding. One of the key components utilized during the past nine years to achieve these goals has been Pilot Project Programs, which have been part of the Adiministrative Core of our Phase I and Phase II grants. These programs have been instrumental in expanding the scope of the Center, accelerating productivity of collaborative studies, and increasing infectious disease grant funding in Montana. These achievements have significantly contributed to the growth of the COBRE Center and continue to foster its evolution into a sustainable Center at Montana State University. In Phase III, we propose an enhanced Pilot Grants Program so that it not only utilizes the best features identified during COBRE l/ll, but also includes improved elements to address any shortcomings of our prevoius programs. This enhanced Pilot Grants Program emphasizes collaborative, multidisciplinary, translational studies on zoonotic and emerging infectious diseases and includes extensive mentorship, guidance, and evaluation in order to develop these projects so that they can become competitive for major national research grants. To achieve these goals, the Specific Aims of the Pilot Grants Program are:
Specific Aim 1 : to increase the scope and impact of zoonotic and emerging infectious disease research conducted by our COBRE Center, Specific Aim 2: to increase support of collaborative studies that lead toward larger program-type grants, and Specific Aim 3: to increase utilization of Center Scientific Core research facilities. Proposals for Pilot Grants will be solicited on a yeariy basis using an request for applications (RFA) mechanism and will be reviewed by a panel consisting of the Steering Committee and External Advisory Committee members and other experts as needed. Awards will be for one year, with the possibility of renewal for a second year. The general criteria for selection will include: responsiveness to the solicitation specifications, likelihood the pilot studies will lead to longer term funding, excellence of the science, and alignment of the project with the mission of our COBRE Center. Based on our past record of success with Pilot Projects and the enhancements proposed under COBRE III, we feel confident that this program will significantly enhance the competitiveness of our research programs and contribute to the overall quality and impact of the COBRE Center.

Public Health Relevance

Pilot Grants represent an essential component ofthe COBRE III Center by expanding the scope and impact of our research. Through the use of an RFA and panel review mechanism, excellent projects focused on important questions in zoonotic and emerging infectious diseases and with high potential for future funding will be identified and supported.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Montana State University - Bozeman
United States
Zip Code
Plowright, Raina K; Parrish, Colin R; McCallum, Hamish et al. (2017) Pathways to zoonotic spillover. Nat Rev Microbiol 15:502-510
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2017) Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Dev Res 78:49-62
Páez, D J; Giles, J; McCallum, H et al. (2017) Conditions affecting the timing and magnitude of Hendra virus shedding across pteropodid bat populations in Australia. Epidemiol Infect 145:3143-3153
Jackson, Ryan N; van Erp, Paul Bg; Sternberg, Samuel H et al. (2017) Conformational regulation of CRISPR-associated nucleases. Curr Opin Microbiol 37:110-119
Kirpotina, Liliya N; Schepetkin, Igor A; Khlebnikov, Andrei I et al. (2017) 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists. Biochem Pharmacol 142:120-132
Stama, Madia Letizia; ?lusarczyk, Joanna; Lacivita, Enza et al. (2017) Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation. Eur J Med Chem 141:703-720
Özek, Gulmira; Schepetkin, Igor A; Utegenova, Gulzhakhan A et al. (2017) Chemical composition and phagocyte immunomodulatory activity of Ferula iliensis essential oils. J Leukoc Biol 101:1361-1371
Halonen, Sandra K (2017) Use of Human Neurons Derived via Cellular Reprogramming Methods to Study Host-Parasite Interactions of Toxoplasma gondii in Neurons. Cells 6:
Roe, Mandi M; Swain, Steve; Sebrell, T Andrew et al. (2017) Differential regulation of CD103 (?E integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands. J Leukoc Biol 101:1169-1180
Brutscher, Laura M; Daughenbaugh, Katie F; Flenniken, Michelle L (2017) Virus and dsRNA-triggered transcriptional responses reveal key components of honey bee antiviral defense. Sci Rep 7:6448

Showing the most recent 10 out of 90 publications